Unbound MEDLINE

Simulation of functional tricuspid regurgitation using an isolated porcine heart model.

Abstract

BACKGROUND AND AIM OF THE STUDY
The results of tricuspid annuloplasty to treat functional tricuspid regurgitation (FTR) are sometimes suboptimal, and alternative techniques are needed. In the absence of reliable FTR models, and in an effort to minimize the need for animal experiments, a reproducible bench-model was developed of FTR, that allowed the simulation of the anatomic features of the condition.
METHODS
A fresh porcine heart was mounted on a rigid support that was placed into a basin filled with saline; a closed circuit was then created with a centrifugal pump, equipped with connection tubes. The inflow tube of the pump conveyed saline from the basin to the pump; the outflow cannula was inserted through the pulmonary artery, across the pulmonary valve, into the right ventricle. The pump was activated to pressurize the right ventricle, thus inducing tricuspid valve regurgitation (TVR). The regurgitant flow through the valve was quantified using a flow-meter. Radiopaque markers were sutured to the head of each papillary muscle and to the tricuspid annulus, in order to trace the geometric changes of the tricuspid valve at increasing pump rates, using fluoroscopy. The efficacy of the bench-model was validated with 10 hearts.
RESULTS
The TVR was increased proportionally with the right ventricular pressure (RVP) (TVR = 0.089xRVP - 1.515; R2 = 0.89). The increase in TVR was associated with increases in the annular-to-papillary muscles distance (APML) (TVR = 0.059xAPML - 2.94; R2 = 0.96), of the inter-papillary muscles distance (PMD) (TVR = 0.058xPMD - 8.58; R2 = 0.94), and of the triscuspid annular dilatation (TAD) (TVR = 0.05xTAD - 1.85; R2 = 0.89). Of these parameters, APML was the strongest predictor of TVR.
CONCLUSION
The porcine heart bench model represents a reproducible system to simulate the physiopathology of FTR, and has the potential to serve as a complementary method for the evaluation of new 'in vitro' technologies and therapies for FTR.

Authors

Maisano F, Taramasso M, Guidotti A, Redaelli A, Fiore GB, Baroni G, Patete P, Alfieri O

Institution

Cardiac Surgery Department, Ospedale San Raffaele, Milan, Italy. francesco.maisano@hsr.it

Source

The Journal of heart valve disease 20:6 2011 Nov pg 657-63

MeSH

Animals
Disease Models, Animal
Swine
Systole
Tricuspid Valve
Tricuspid Valve Insufficiency
Ventricular Function, Right

Pub Type(s)

In Vitro
Journal Article
Validation Studies

Language

eng

PubMed ID

22655496